Author: Claudinne Miller
Study Finds There Are 4 Subtypes of Long COVID
(Prevention) Research has found that long COVID impacts one in five adults under the age of 65, but scientists are still trying to learn more about the condition. Now, a new study has found there are actually four main subtypes of long COVID. The study, which was published in the journal Nature Medicine, used machine learning to analyze clusters of symptoms […]
Jan 10, 2023
Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes
(Nature) The post-acute sequelae of SARS-CoV-2 infection (PASC) refers to a broad spectrum of symptoms and signs that are persistent, exacerbated or newly incident in the period after acute SARS-CoV-2 infection. Most studies have examined these conditions individually without providing evidence on co-occurring conditions. In this study, we leveraged the electronic health record data of […]
Jan 10, 2023
Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate
(Nature)Vaccines against SARS-CoV-2 have been shown to be safe and effective but their protective efficacy against infection in the brain is yet unclear. Here, in the susceptible transgenic K18-hACE2 mouse model of severe coronavirus disease 2019 (COVID-19), we report a spatiotemporal description of SARS-CoV-2 infection and replication through the brain. SARS-CoV-2 brain replication occurs primarily […]
Jan 10, 2023
A Vaccine Against COVID-19 Found to Protect Against Infection and Brain Damage Caused by the Virus
(Neuroscience News) Although the pathology of the respiratory system is the main impact of COVID-19, many patients also manifest important neurological symptoms, such as loss of smell (anosmia), headaches, malaise, cognitive loss, epilepsy, ataxia and encephalopathy, among others. However, this effect on the nervous system by the coronavirus has not been characterized in detail and […]
Jan 10, 2023
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
(Nature) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and spread in 2022 despite the introduction of safe, effective vaccines and medications. Vaccine hesitancy remains substantial, fueled in part by misinformation. Our third study of Coronavirus Disease 2019 (COVID-19) vaccine hesitancy among 23,000 respondents in 23 countries (Brazil, Canada, China, Ecuador, France, Germany, […]
Jan 10, 2023
Most people who ended up with long COVID started with a mild case, new study shows
(CBS News) Even mild COVID-19 cases can have major and long-lasting effects on people’s health. That is one of the key findings from our recent multicountry study on long COVID-19 – or long COVID – recently published in the Journal of the American Medical Association. Long COVID is defined as the continuation or development of symptoms three months after the […]
Jan 10, 2023
UNMC Never Again Summit Series
(UNMC) Please join us for our second chapter of the Global Center for Health Security’s Never Again Summit series as we host guest speaker Dr. Jeremy Farrar. Event Details The Global Center for Health Security is honored to host guest speaker Dr. Jeremy Farrar for a discussion about global health, pandemics, and health security. An […]
Jan 10, 2023
Omicron COVID booster cuts hospitalization in over 65s, Israeli study finds
(Reuters) The Omicron-adapted COVID-19 vaccine booster developed by Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) sharply reduced hospitalizations among older patients, Israeli researchers said on Monday, in some of the first evidence of the jab’s real-world effectiveness.
Jan 9, 2023
FDA releases important information about risk of COVID-19 due to certain variants not neutralized by Evusheld
(FDA) FDA is closely monitoring the emergence of the XBB.1.5 subvariant, a SARS-CoV-2 Omicron variant that is currently estimated to account for 28% of circulating variants in the U.S. Because of its similarity to variants that are not neutralized by Evusheld (e.g., XBB), FDA does not anticipate that Evusheld will neutralize XBB.1.5. This means that Evusheld may […]
Jan 9, 2023
Dr. David Nabarro Knighted by HM The King for Outstanding Contributions to Global Health
(gov.UK) Distinguished international public servant Dr David Nabarro who receives a Knighthood for his outstanding contribution to global health, most recently as the WHO [World Health Organization] Special Envoy for COVID-19 Prevention and Response.
Jan 9, 2023
